Physician profile
Roberta Johnson
NPI 1558070466
$800.70
in general payments reported to CMS, 2019-2025
19 companies · $38.48 in 2025
The $38.48 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $288 · 2024: $475 · 2025: $38.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $801.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $800.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $110.56 | 2024 | Rexulti |
| Corcept Therapeutics | $107.96 | 2023-2024 | Korlym |
| Abbvie INC. | $73.18 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $48.38 | 2023 | |
| Acadia Pharmaceuticals INC | $47.88 | 2024-2025 | Nuplazid |
| Daiichi Sankyo INC. | $47.82 | 2024 | Injectafer |
| Sumitomo Pharma America, INC. | $46.57 | 2024 | Gemtesa |
| Janssen Pharmaceuticals, INC | $44.36 | 2023-2024 | Spravato |
| Lilly USA, LLC | $41.17 | 2023 | Mounjaro, Jardiance |
| Astellas Pharma US INC | $38.64 | 2023-2024 | Veozah |
| Viiv Healthcare Company | $31.34 | 2023 | Apretude |
| Exact Sciences Corporation | $23.52 | 2024 | Cologuard Collection Kit |
| Mylan Specialty L.P. | $22.41 | 2024 | Yupelri |
| Pfizer INC. | $21.82 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $21.70 | 2023 | Lokelma |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $21.37 | 2024 | Uzedy |
| Shield Therapeutics INC | $20.11 | 2023 | Accrufer |
| Biogen, INC. | $17.34 | 2025 | Tysabri, Vumerity |
| Philips North America LLC | $14.57 | 2024 | (Ak6) Vest Therapy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roberta Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.